Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buslei

Showing results (61-70 of 122) with videos related to

Pageof 13
Sort By:
Radiology|August 24, 2006
Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imagingAndreas Stadlbauer, Oliver Ganslandt, Rolf Buslei, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 27, 2016
Erratum to: Primary glioblastoma multiforme tumors and recurrence: comparative analysis of the danger signals HMGB1, HSP70, and calreticulinCarolin Muth, Yvonne Rubner, Sabine Semrau, et al.
Scientific Reports|November 22, 2017
Expression of SRY-related HMG Box Transcription Factors (Sox) 2 and 9 in Craniopharyngioma Subtypes and Surrounding Brain TissueVivian Thimsen, Nora John, Michael Buchfelder, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|October 1, 1996
NeuN: a useful neuronal marker for diagnostic histopathologyH K Wolf, R Buslei, R Schmidt-Kastner, et al.
Radiation Oncology (London, England)|April 1, 2014
Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell linesYvonne Rubner, Carolin Muth, Annedore Strnad, et al.
Acta Neuropathologica|January 20, 2006
Abundant hypermethylation of SOCS-1 in clinically silent pituitary adenomasRolf Buslei, Jürgen Kreutzer, Bernd Hofmann, et al.
Pituitary|January 9, 2016
Diagnosis and management of acromegaly: the patient's perspectiveIlonka Kreitschmann-Andermahr, Sonja Siegel, Bernadette Kleist, et al.
Brain Pathology (Zurich, Switzerland)|April 11, 2014
Insights into the infiltrative behavior of adamantinomatous craniopharyngioma in a new xenotransplant mouse modelChristina Stache, Annett Hölsken, Sven-Martin Schlaffer, et al.
Neuroimage|December 15, 2006
Diffusion tensor imaging and optimized fiber tracking in glioma patients: Histopathologic evaluation of tumor-invaded white matter structuresAndreas Stadlbauer, Christopher Nimsky, Rolf Buslei, et al.
CNS Neuroscience & Therapeutics|May 31, 2017
Pituicytoma-An outlook on possible targeted therapiesKlaus Christian Mende, Jakob Matschke, Till Burkhardt, et al.
Pageof 13

Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
Radiology|August 24, 2006
Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imagingAndreas Stadlbauer, Oliver Ganslandt, Rolf Buslei, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 27, 2016
Erratum to: Primary glioblastoma multiforme tumors and recurrence: comparative analysis of the danger signals HMGB1, HSP70, and calreticulinCarolin Muth, Yvonne Rubner, Sabine Semrau, et al.
Scientific Reports|November 22, 2017
Expression of SRY-related HMG Box Transcription Factors (Sox) 2 and 9 in Craniopharyngioma Subtypes and Surrounding Brain TissueVivian Thimsen, Nora John, Michael Buchfelder, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|October 1, 1996
NeuN: a useful neuronal marker for diagnostic histopathologyH K Wolf, R Buslei, R Schmidt-Kastner, et al.
Radiation Oncology (London, England)|April 1, 2014
Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell linesYvonne Rubner, Carolin Muth, Annedore Strnad, et al.
Acta Neuropathologica|January 20, 2006
Abundant hypermethylation of SOCS-1 in clinically silent pituitary adenomasRolf Buslei, Jürgen Kreutzer, Bernd Hofmann, et al.
Pituitary|January 9, 2016
Diagnosis and management of acromegaly: the patient's perspectiveIlonka Kreitschmann-Andermahr, Sonja Siegel, Bernadette Kleist, et al.
Brain Pathology (Zurich, Switzerland)|April 11, 2014
Insights into the infiltrative behavior of adamantinomatous craniopharyngioma in a new xenotransplant mouse modelChristina Stache, Annett Hölsken, Sven-Martin Schlaffer, et al.
Neuroimage|December 15, 2006
Diffusion tensor imaging and optimized fiber tracking in glioma patients: Histopathologic evaluation of tumor-invaded white matter structuresAndreas Stadlbauer, Christopher Nimsky, Rolf Buslei, et al.
CNS Neuroscience & Therapeutics|May 31, 2017
Pituicytoma-An outlook on possible targeted therapiesKlaus Christian Mende, Jakob Matschke, Till Burkhardt, et al.
Pageof 13